8-K: Research Solutions Reports Record FY26 Net Income, AI ARR Growth

Sentiment:

Quarterly and Annual Results


Research Solutions announced record fiscal year net income of $2.8 million and a 14% year-over-year increase in B2B ARR to $16.2 million, driven by AI product launches and a platform mix shift.

Summary

  • Research Solutions reported financial results for the fourth quarter and full fiscal year ended June 30, 2026.
  • For the full fiscal year 2026, total revenue was $48.3 million, a slight decrease of 1.5% from $49.1 million in fiscal 2025.
  • Platform revenue increased by 9.8% to $20.8 million, now representing 43% of total revenue, up from 39% in the prior year.
  • Transaction revenue decreased by 8.7% to $27.5 million.
  • Total gross profit increased by 3.6% to $25.1 million, with gross margin improving 260 basis points to 51.9% due to the platform mix shift.
  • Net income for the full year was $2.8 million ($0.09 per diluted share), a significant increase from $1.3 million ($0.04 per diluted share) in fiscal 2025.
  • Adjusted EBITDA reached a record $5.8 million, up 10.6% from $5.3 million in fiscal 2025.
  • B2B ARR grew 14.1% to $16.2 million, including $0.8 million in AI-related ARR.
  • Total ARR was $22.5 million, up 7.8% year-over-year.
  • The company ended the fiscal year with $12.6 million in cash and cash equivalents.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong growth in platform revenue and AI-related ARR, alongside record Adjusted EBITDA, indicating a healthy shift towards higher-margin offerings despite a slight overall revenue dip.

Positives

  • Record fiscal year net income of $2.8 million, more than doubling from $1.3 million in the prior year.
  • Record Adjusted EBITDA of $5.8 million, an increase of 10.6% year-over-year.
  • Significant growth in platform revenue, up 9.8% to $20.8 million, and now representing 43% of total revenue.
  • Improvement in total gross margin by 260 basis points to 51.9%, driven by the shift to higher-margin platform offerings.
  • B2B ARR increased by 14.1% to $16.2 million.
  • AI-related ARR grew to $0.8 million, with a 125% sequential increase in the fourth quarter.
  • Total ARR increased by 7.8% to $22.5 million.
  • Strong cash position with $12.6 million in cash and cash equivalents at year-end.

Negatives

  • Total revenue decreased by 1.5% to $48.3 million.
  • Transaction revenue decreased by 8.7% to $27.5 million due to lower paid order volume.
  • Cash flow from operations decreased to $5.3 million from $7.0 million, attributed to the timing of working capital payments.
  • Fourth-quarter net income decreased to $666,000 ($0.02 per diluted share) from $2.4 million ($0.07 per diluted share) in the prior year, which included a favorable $1.1 million adjustment for the Scite earnout.
  • Fourth-quarter Adjusted EBITDA decreased by 11.4% to $1.4 million from $1.6 million in the prior year.

Risks

  • The company's forward-looking statements are subject to risks, uncertainties, and assumptions that are difficult to predict, estimate, or verify, and actual results may differ materially.
  • Factors described in the Company's most recent annual report on Form 10-K may impact future performance.
  • A decline in B2C ARR was noted, although offset by B2B ARR growth.

Future Outlook

The company is well-positioned to continue investing in internally developed tools and pursue strategic M&A. The launch of new AI products is expected to create a large pipeline of AI-related revenue opportunities in FY27, supporting users within their existing AI tools.

Management Comments

  • "Platform revenue grew to 43% of total revenue, up from 39% in fiscal 2025. That mix shift expanded gross margin and helped us more than double net income for the full year in a challenging market."
  • "With a strong cash position and Adjusted EBITDA posture, we're well-positioned to continue investing in internally developed tools and to pursue strategic M&A that complements our current offerings."
  • "This is part of our strategy to support our users where they work and has resulted in us building a large pipeline of AI related revenue opportunities in FY27."

Industry Context

StockSavvy.ai notes that Research Solutions' focus on AI-powered tools and integration into existing researcher workflows (like ChatGPT, Claude, Copilot) aligns with the broader industry trend of leveraging AI to enhance productivity and discovery in scientific research. The shift towards a higher-margin SaaS platform model is a common and positive strategy for vertical SaaS companies.

Stakeholder Impact

  • Shareholders: Potential for increased value due to record net income, record Adjusted EBITDA, and strategic shift towards higher-margin recurring revenue.
  • Customers: Benefit from enhanced AI-powered research tools and seamless integration into their existing workflows.
  • Employees: May see continued investment in product development and potential growth opportunities within the company.
  • Suppliers/Creditors: The company's strong cash position and improved profitability provide a stable financial footing.

Next Steps

  • Continue investing in internally developed tools.
  • Pursue strategic M&A opportunities.
  • Capitalize on the pipeline of AI-related revenue opportunities in FY27.
  • Support users within their existing AI tools.

Key Dates

DateDescription
June 30, 2025End of Fiscal Year 2025
June 30, 2026End of Fiscal Year 2026
September 9, 2026Date of Report and Press Release Announcement
October 9, 2026End of replay availability for conference call

Recommendation

hold

The company is demonstrating positive strategic execution with strong growth in its higher-margin platform business and record profitability metrics. However, the overall revenue decline and the prior year's results being inflated by an earnout adjustment warrant a cautious approach. While the AI integration and ARR growth are promising, continued execution and stabilization of overall revenue are key for a stronger buy recommendation.

Keywords

AI-powered research, SaaS platform, Annual Recurring Revenue, Adjusted EBITDA, Platform revenue, Fiscal year results, Scientific literature, Research workflow

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.